Use of Cavilon (Dimethicone) for Skin Breakdown Prevention
Cavilon (dimethicone) should be used as a barrier product to prevent skin breakdown in patients at high risk of skin damage due to moisture, friction, or irritants, particularly in cases of incontinence, wound drainage, or in immobile patients with stroke or other conditions that limit movement.
Risk Assessment and Indications
- A thorough assessment of skin integrity should be completed on admission and monitored at least daily for patients at risk of skin breakdown 1
- Patients at highest risk for skin breakdown include those with:
Mechanism and Benefits
Cavilon (dimethicone) acts as a protective barrier that:
Barrier films like Cavilon No Sting Barrier Film have demonstrated:
Application Guidelines
Apply Cavilon as part of a comprehensive skin care regimen that includes:
For specific skin conditions:
- For peristomal leakage: Apply zinc oxide-based skin protectants (including dimethicone products like Cavilon) to protect surrounding skin 1
- For excessive granulation tissue: Use barrier films to protect surrounding skin 1
- For incontinence-associated dermatitis: Apply barrier creams after cleansing and before moisture exposure 3, 4
Special Considerations for Stroke Patients
Stroke patients are at particularly high risk for skin breakdown due to:
For stroke patients, integrate Cavilon use with:
Common Pitfalls and Caveats
- Barrier products alone are insufficient without addressing the underlying causes of moisture or irritation 2
- Skin should be properly cleansed before applying barrier products 4
- Over-application can lead to product buildup, which may trap moisture against the skin 2
- Different formulations (films vs. creams) have different indications and durability 3
- Ensure proper education of patients, staff, and caregivers about skin breakdown prevention 1
Monitoring and Reassessment
- Continue daily skin assessments while risk factors persist 1
- Use validated tools like the Braden scale to predict pressure ulcer risk 1
- Reassess the need for barrier products as the patient's condition changes 1
- Monitor for signs of skin breakdown despite preventive measures and adjust care plan accordingly 1